elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34975423-556D9A40-9889-4348-A38F-DE398BB3E641
Q34975423-556D9A40-9889-4348-A38F-DE398BB3E641
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34975423-556D9A40-9889-4348-A38F-DE398BB3E641
Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors.
P50
Q34975423-556D9A40-9889-4348-A38F-DE398BB3E641
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34975423-556D9A40-9889-4348-A38F-DE398BB3E641
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f260292eabfb5bc30fd1530d897a0195f01de0d5
P1545
8
http://www.w3.org/2001/XMLSchema#string
P50
Erik Wiemer